Ru Ma

1.4k total citations
64 papers, 1.1k citations indexed

About

Ru Ma is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Ru Ma has authored 64 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 14 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Ru Ma's work include Intraperitoneal and Appendiceal Malignancies (22 papers), Appendicitis Diagnosis and Management (12 papers) and Occupational and environmental lung diseases (11 papers). Ru Ma is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (22 papers), Appendicitis Diagnosis and Management (12 papers) and Occupational and environmental lung diseases (11 papers). Ru Ma collaborates with scholars based in China, United States and United Kingdom. Ru Ma's co-authors include Zhiwei Sun, Caixia Guo, Yanbo Li, Xinying Zhao, Xianqing Zhou, Alimire Abulikemu, Yan Li, Yi Qi, Xiaoying Liu and Junchao Duan and has published in prestigious journals such as Nature Materials, The Science of The Total Environment and Journal of Hazardous Materials.

In The Last Decade

Ru Ma

60 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ru Ma China 18 377 199 159 144 141 64 1.1k
Sabine U. Vorrink Sweden 15 425 1.1× 132 0.7× 106 0.7× 261 1.8× 142 1.0× 18 1.2k
Xinying Zhao China 18 356 0.9× 139 0.7× 128 0.8× 103 0.7× 128 0.9× 39 1.0k
Guoping Zhao China 20 468 1.2× 155 0.8× 124 0.8× 81 0.6× 158 1.1× 50 1.0k
Jinfang Zhao China 15 192 0.5× 266 1.3× 183 1.2× 57 0.4× 93 0.7× 24 984
Qin Hu China 22 606 1.6× 113 0.6× 83 0.5× 189 1.3× 76 0.5× 72 1.3k
Ge Xu China 22 684 1.8× 315 1.6× 363 2.3× 168 1.2× 130 0.9× 52 1.7k
Houxiang Hu China 18 489 1.3× 71 0.4× 103 0.6× 101 0.7× 58 0.4× 60 1.0k
Ai Gao China 24 672 1.8× 133 0.7× 123 0.8× 111 0.8× 260 1.8× 98 1.6k
Naoki Nanashima Japan 18 295 0.8× 187 0.9× 95 0.6× 86 0.6× 52 0.4× 51 933
Nandini D.P.K. Manne United States 16 288 0.8× 479 2.4× 122 0.8× 164 1.1× 80 0.6× 35 1.2k

Countries citing papers authored by Ru Ma

Since Specialization
Citations

This map shows the geographic impact of Ru Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru Ma more than expected).

Fields of papers citing papers by Ru Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ru Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru Ma. The network helps show where Ru Ma may publish in the future.

Co-authorship network of co-authors of Ru Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Ru Ma. A scholar is included among the top collaborators of Ru Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ru Ma. Ru Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jinze, Haiyang Cheng, Ru Ma, et al.. (2025). Scalable ruthenium core–shell hydrogen catalyst for efficient and robust proton-exchange membrane electrolyser. Nature Materials. 25(2). 238–248.
3.
Wang, Yi, Rui Yang, Xin‐Li Liang, et al.. (2025). Elevated Proportion of Tumor-Infiltrating Natural Killer Cells Predicts Improved Survival in Peritoneal Mesothelioma: A Single-Center Study of 109 Cases. Annals of Surgical Oncology. 33(1). 789–799. 1 indexed citations
4.
Wang, Junqing, Yulin Lin, Ru Ma, et al.. (2024). Potential treatment approaches for malignant peritoneal mesothelioma: in vivo and in vitro experimental study of natural killer cell immunotherapy. Cancer Biology and Medicine. 21(11). 1–17. 5 indexed citations
5.
Liang, Xin‐Li, et al.. (2024). Risk factors and prognosis of malignant peritoneal mesothelioma with paraneoplastic syndrome. World Journal of Surgical Oncology. 22(1). 29–29. 1 indexed citations
6.
Liang, Xin‐Li, et al.. (2024). Effect of postoperative normothermic intraperitoneal chemotherapy on the prognosis of MPM patients receiving CRS+HIPEC: A single-center case-control study. European Journal of Surgical Oncology. 50(11). 108692–108692. 1 indexed citations
7.
Ma, Ru, et al.. (2024). Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei. Cancer Biology and Medicine. 21(7). 1–20. 2 indexed citations
8.
Guo, Caixia, Xinying Zhao, Ru Ma, et al.. (2023). Silica nanoparticles promoted pro-inflammatory macrophage and foam cell transformation via ROS/PPARγ/NF-κB signaling. The Science of The Total Environment. 881. 163430–163430. 16 indexed citations
10.
Yang, Rui, et al.. (2023). Long-term survival in patients with PMP: a single-institutional retrospective study from China. World Journal of Surgical Oncology. 21(1). 347–347. 4 indexed citations
11.
Yan, Lijun, et al.. (2022). NPM2 in malignant peritoneal mesothelioma: from basic tumor biology to clinical medicine. World Journal of Surgical Oncology. 20(1). 141–141. 4 indexed citations
12.
Zhang, Jue, Xin-Bao Li, Zhong‐He Ji, et al.. (2021). Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival with Acceptable Safety for Advanced Ovarian Cancer: A Clinical Study of 100 Patients. BioMed Research International. 2021(1). 5533134–5533134. 8 indexed citations
13.
Liu, Xiaoying, Xinying Zhao, Xueyan Li, et al.. (2020). PM2.5 triggered apoptosis in lung epithelial cells through the mitochondrial apoptotic way mediated by a ROS-DRP1-mitochondrial fission axis. Journal of Hazardous Materials. 397. 122608–122608. 77 indexed citations
14.
Li, Xin-Bao, Ru Ma, Zhong‐He Ji, et al.. (2020). Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center. European Journal of Surgical Oncology. 46(4). 600–606. 19 indexed citations
15.
16.
Guo, Caixia, Ru Ma, Xiaoying Liu, et al.. (2018). Silica nanoparticles promote oxLDL-induced macrophage lipid accumulation and apoptosis via endoplasmic reticulum stress signaling. The Science of The Total Environment. 631-632. 570–579. 76 indexed citations
17.
Ma, Ru, et al.. (2017). Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents. Bioorganic & Medicinal Chemistry. 26(3). 609–622. 18 indexed citations
18.
Huang, Chuanshu, Ru Ma, Shan Sun, et al.. (2008). JAK2-STAT3 signaling pathway mediates thrombin-induced proinflammatory actions of microglia in vitro. Journal of Neuroimmunology. 204(1-2). 118–125. 73 indexed citations
19.
Huang, Jianyu, Yang Cao, Jing Du, et al.. (2007). Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses. Vaccine. 25(39-40). 6981–6991. 54 indexed citations
20.
Lü, Di, Hongzhang Chen, & Ru Ma. (2006). Effect of Straw Apoplast Protein on Cellulase Activity. Chinese journal of biotechnology/Shengwu gongcheng xuebao. 22(2). 257–262. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026